FDA allows Aethlon to test Hemopurifier for HCV treatment

06/27/2013 | MedGadget.com

The FDA has granted Aethlon Medical investigational device exemption approval to conduct human feasibility trials of its Hemopurifier system, which is used in extracorporeal blood filtration procedures. The San Diego company will initially test the device in 10 end-stage renal disease patients infected with the hepatitis C virus.

View Full Article in:

MedGadget.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ